Literature DB >> 10503061

Benign prostatic hyperplasia (the aging prostate).

J J Medina1, R O Parra, R G Moore.   

Abstract

BPH is a common phenomenon of the aging process. Clinical manifestations may range from minimally bothersome symptoms to urinary retention and renal failure. Tailoring of treatment based on the individual patient is required for successful management. For mild symptoms, watchful waiting is a valid option. For severe symptoms, surgical therapy is most appropriate. For men complaining of moderate symptoms, medical therapy has become front-line therapy, with other less invasive treatment modalities being available or in development.

Entities:  

Mesh:

Year:  1999        PMID: 10503061     DOI: 10.1016/s0025-7125(05)70159-0

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  12 in total

1.  [Finasteride in the treatment of benign prostatic hyperplasia].

Authors:  T Ząbkowski
Journal:  Urologe A       Date:  2012-07       Impact factor: 0.639

2.  Medical therapy for benign prostatic hyperplasia: new terminology, new concepts, better choices.

Authors:  Steven A Kaplan
Journal:  Rev Urol       Date:  2006

3.  Symptomatic and asymptomatic benign prostatic hyperplasia: molecular differentiation by using microarrays.

Authors:  Kulkarni Prakash; Gregorio Pirozzi; Michael Elashoff; William Munger; Iwao Waga; Rajiv Dhir; Yoshiyuki Kakehi; Robert H Getzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

4.  Quality of life and sexual function in patients with benign prostatic hyperplasia.

Authors:  Reginald C Bruskewitz
Journal:  Rev Urol       Date:  2003

5.  Validity of the "bother score" in the evaluation and treatment of symptomatic benign prostatic hyperplasia.

Authors:  Michael P O'leary
Journal:  Rev Urol       Date:  2005

6.  Effects of low-dose tamsulosin on sexual function in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.

Authors:  Sin Wook Kim; Wan Cheol Lee; Ma Tae Kim; Kyungtae Ko; Won Ki Lee; Choong-Hyun Lee; Je Jong Kim; Dae Yul Yang
Journal:  Korean J Urol       Date:  2013-10-15

7.  Severity of Lower Urinary Tract Symptoms among Middle Aged and Elderly Nigerian Men: Impact on Quality of Life.

Authors:  Patrick Temi Adegun; Philip Babatunde Adebayo; Peter Olufemi Areo
Journal:  Adv Urol       Date:  2016-06-19

8.  Integrated Item Response Theory Modeling of Multiple Patient-Reported Outcomes Assessing Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia.

Authors:  Yassine Kamal Lyauk; Trine Meldgaard Lund; Andrew C Hooker; Mats O Karlsson; Daniël M Jonker
Journal:  AAPS J       Date:  2020-07-29       Impact factor: 4.009

Review 9.  Doxazosin in the treatment of benign prostatic hypertrophy: an update.

Authors:  Timothy J Wilt; Roderick MacDonald
Journal:  Clin Interv Aging       Date:  2006       Impact factor: 4.458

10.  Item Response Theory Modeling of the International Prostate Symptom Score in Patients with Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia.

Authors:  Yassine Kamal Lyauk; Daniël M Jonker; Trine Meldgaard Lund; Andrew C Hooker; Mats O Karlsson
Journal:  AAPS J       Date:  2020-08-27       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.